Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Low Diastolic Blood Pressure Linked to Subclinical Myocardial Damage and Coronary Events: ARIC Analysis

Michael O'Riordan

October 06, 2016

News Features

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Michael O'Riordan

October 05, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

不同次复诊时收缩压大幅波动与死亡风险升高相关

Michael O'Riordan

September 27, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Daily News

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Michael O'Riordan

September 27, 2016

News Daily News

Large Swings in Visit-to-Visit Systolic Blood Pressure Linked With Increased Risk of Death

Michael O'Riordan

September 27, 2016

News Daily News

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

Michael O'Riordan

September 15, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Daily News

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Michael O'Riordan

June 24, 2016

News Daily News

Low-Dose Alteplase Not as Effective as Standard-Dose in Acute Ischemic Stroke

Michael O'Riordan

May 12, 2016

News Daily News

¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos

Michael O'Riordan

May 02, 2016

News Daily News

TAVR 是否需要预扩张？欧洲系列研究对两者都提供支持

Michael O'Riordan

May 02, 2016

News Daily News

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

Michael O'Riordan

May 02, 2016

News Daily News

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Michael O'Riordan

March 14, 2016

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

Advertisement

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Low Diastolic Blood Pressure Linked to Subclinical Myocardial Damage and Coronary Events: ARIC Analysis

Sodium Wars: Where Some See Linear Link With All-Cause Death, Others See No Need to Change Western Ways

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

不同次复诊时收缩压大幅波动与死亡风险升高相关

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Los Grandes Cambios en la Presión Arterial Sistólica de una Visita Médica a Otra se asocian a un Mayor Riesgo de Mortalidad

Large Swings in Visit-to-Visit Systolic Blood Pressure Linked With Increased Risk of Death

Intensive SPRINT Blood Pressure Reduction Would Prevent 100,000 Deaths per Year

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Black Individuals Have Less A-fib, but When They Do, the Consequences Are More Dire

Low-Dose Alteplase Not as Effective as Standard-Dose in Acute Ischemic Stroke

¿Predilatación o No Predilatación en TAVR? Una Serie Europea Tranquiliza en Ambos Sentidos

TAVR 是否需要预扩张？欧洲系列研究对两者都提供支持

Predilatation or No Predilatation in TAVR? European Series Offers Reassurances Both Ways

卒中率下降使人质疑是否有必要在 TAVR 中置入血栓预防设备

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content